Global Pharmaceutical Products Testing Market Growth (Status and Outlook) 2025-2031

The global Pharmaceutical Products Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Pharmaceutical Products Testing Industry Forecast” looks at past sales and reviews total world Pharmaceutical Products Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Products Testing sales for 2025 through 2031. With Pharmaceutical Products Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Products Testing industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Products Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Products Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Products Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Products Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Products Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Products Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Raw Materials Testing
In-Process and Product Release Testing
Finished Pharmaceutical Products Testing
Environmental Samples Testing
Others

Segmentation by Application:
Pharmaceutical Industry
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
Envigo
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
EAG
DYNALABS
Maxxam
ARLBioPharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions

Please note: The report will take approximately 2 business days to prepare and deliver.